Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis

Abstract To evaluate the accuracy of biomarkers for the early diagnosis of biliary atresia (BA) and prognostic stratification after Kasai portoenterostomy (KPE). We conducted a systematic review of PubMed, Web of Science, Embase, Scopus and OVID for English literature reporting BA biomarkers publish...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lin He, Dennis Kai Ming Ip, Greta Tam, Vincent Chi Hang Lui, Paul Kwong Hang Tam, Patrick Ho Yu Chung
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a955149154d04b84b8c5ecae5beaf15d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a955149154d04b84b8c5ecae5beaf15d
record_format dspace
spelling oai:doaj.org-article:a955149154d04b84b8c5ecae5beaf15d2021-12-02T15:02:57ZBiomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis10.1038/s41598-021-91072-y2045-2322https://doaj.org/article/a955149154d04b84b8c5ecae5beaf15d2021-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-91072-yhttps://doaj.org/toc/2045-2322Abstract To evaluate the accuracy of biomarkers for the early diagnosis of biliary atresia (BA) and prognostic stratification after Kasai portoenterostomy (KPE). We conducted a systematic review of PubMed, Web of Science, Embase, Scopus and OVID for English literature reporting BA biomarkers published before August 2020. Screening, data extraction, and quality assessment were performed in duplicate. A total of 51 eligible studies were included in the systematic review, and data from 12 (4182 subjects) were extracted for meta-analysis regarding the following 2 domains: (1) serum matrix metallopeptidase-7 (MMP-7), interleukin33 (IL-33) and γ-glutamyl transferase (GGT) to differentiate BA from non-BA; (2) the aspartate aminotransferase to platelet ratio index (APRi) to predict post-KPE liver fibrosis/cirrhosis. The summary sensitivity, specificity and area under the curve (AUC) of MMP-7 for diagnosing BA were 96%, 91% and 0.9847, respectively, and those of GGT were 80%, 79% and 0.9645, respectively. The summary sensitivity and specificity of IL-33 for diagnosing BA were 77% and 85%, respectively. The summary sensitivity and specificity of APRi for predicting post-KPE liver fibrosis were 61% and 80%, respectively, and the summary sensitivity, specificity and AUC of APRi for predicting post-KPE cirrhosis were 78%, 83% and 0.8729, respectively. Moreover, good evidence was shown in investigations of serum IL-18 and IL-33 in distinguishing BA from healthy controls, serum IL-18 for prognosis of post-KPE persistent jaundice, and serum hyaluronic acid and MMP-7 for prognosis of post-KPE significant liver fibrosis. MMP-7, IL-33 and GGT are useful biomarkers to assist in the diagnosis of BA. APRi might be used to predict post-KPE significant liver fibrosis and cirrhosis. These noninvasive biomarkers can be integrated into the management protocol of BA.Lin HeDennis Kai Ming IpGreta TamVincent Chi Hang LuiPaul Kwong Hang TamPatrick Ho Yu ChungNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Lin He
Dennis Kai Ming Ip
Greta Tam
Vincent Chi Hang Lui
Paul Kwong Hang Tam
Patrick Ho Yu Chung
Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
description Abstract To evaluate the accuracy of biomarkers for the early diagnosis of biliary atresia (BA) and prognostic stratification after Kasai portoenterostomy (KPE). We conducted a systematic review of PubMed, Web of Science, Embase, Scopus and OVID for English literature reporting BA biomarkers published before August 2020. Screening, data extraction, and quality assessment were performed in duplicate. A total of 51 eligible studies were included in the systematic review, and data from 12 (4182 subjects) were extracted for meta-analysis regarding the following 2 domains: (1) serum matrix metallopeptidase-7 (MMP-7), interleukin33 (IL-33) and γ-glutamyl transferase (GGT) to differentiate BA from non-BA; (2) the aspartate aminotransferase to platelet ratio index (APRi) to predict post-KPE liver fibrosis/cirrhosis. The summary sensitivity, specificity and area under the curve (AUC) of MMP-7 for diagnosing BA were 96%, 91% and 0.9847, respectively, and those of GGT were 80%, 79% and 0.9645, respectively. The summary sensitivity and specificity of IL-33 for diagnosing BA were 77% and 85%, respectively. The summary sensitivity and specificity of APRi for predicting post-KPE liver fibrosis were 61% and 80%, respectively, and the summary sensitivity, specificity and AUC of APRi for predicting post-KPE cirrhosis were 78%, 83% and 0.8729, respectively. Moreover, good evidence was shown in investigations of serum IL-18 and IL-33 in distinguishing BA from healthy controls, serum IL-18 for prognosis of post-KPE persistent jaundice, and serum hyaluronic acid and MMP-7 for prognosis of post-KPE significant liver fibrosis. MMP-7, IL-33 and GGT are useful biomarkers to assist in the diagnosis of BA. APRi might be used to predict post-KPE significant liver fibrosis and cirrhosis. These noninvasive biomarkers can be integrated into the management protocol of BA.
format article
author Lin He
Dennis Kai Ming Ip
Greta Tam
Vincent Chi Hang Lui
Paul Kwong Hang Tam
Patrick Ho Yu Chung
author_facet Lin He
Dennis Kai Ming Ip
Greta Tam
Vincent Chi Hang Lui
Paul Kwong Hang Tam
Patrick Ho Yu Chung
author_sort Lin He
title Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
title_short Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
title_full Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
title_fullStr Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
title_full_unstemmed Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
title_sort biomarkers for the diagnosis and post-kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a955149154d04b84b8c5ecae5beaf15d
work_keys_str_mv AT linhe biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
AT denniskaimingip biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
AT gretatam biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
AT vincentchihanglui biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
AT paulkwonghangtam biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
AT patrickhoyuchung biomarkersforthediagnosisandpostkasaiportoenterostomyprognosisofbiliaryatresiaasystematicreviewandmetaanalysis
_version_ 1718389096273936384